Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 132

1.

Predicting Mortality After Transcatheter Aortic Valve Replacement: External Validation of the Transcatheter Valve Therapy Registry Model.

Pilgrim T, Franzone A, Stortecky S, Nietlispach F, Haynes AG, Tueller D, Toggweiler S, Muller O, Ferrari E, Noble S, Maisano F, Jeger R, Roffi M, Grünenfelder J, Huber C, Wenaweser P, Windecker S.

Circ Cardiovasc Interv. 2017 Nov;10(11). pii: e005481. doi: 10.1161/CIRCINTERVENTIONS.117.005481.

PMID:
29127116
2.

Transcatheter Aortic Valve Replacement in Patients With Chronic Lung Disease: Utile or Futile?

Lanz J, Pilgrim T.

JACC Cardiovasc Interv. 2017 Oct 25. pii: S1936-8798(17)31620-5. doi: 10.1016/j.jcin.2017.08.005. [Epub ahead of print] No abstract available.

PMID:
29102576
3.

Dual antiplatelet therapy for secondary prevention of coronary artery disease.

Degrauwe S, Pilgrim T, Aminian A, Noble S, Meier P, Iglesias JF.

Open Heart. 2017 Oct 15;4(2):e000651. doi: 10.1136/openhrt-2017-000651. eCollection 2017. Review.

4.

Incidence and impact of renal dysfunction on clinical outcomes after transcatheter aortic valve implantation.

Franzone A, Stortecky S, Pilgrim T, Asami M, Lanz J, Heg D, Langhammer B, Piccolo R, Lee JKT, Praz F, Räber L, Valgimigli M, Roost E, Windecker S.

Int J Cardiol. 2017 Oct 3. pii: S0167-5273(17)33885-8. doi: 10.1016/j.ijcard.2017.09.201. [Epub ahead of print]

PMID:
28993000
5.

Strategies for Paravalvular Prosthetic Leak Closure: Competing or Complementary?

Pilgrim T, Franzone A.

JACC Cardiovasc Interv. 2017 Oct 9;10(19):1970-1972. doi: 10.1016/j.jcin.2017.08.034. No abstract available.

PMID:
28982561
6.

Transcatheter aortic valve thrombosis: incidence, clinical presentation and long-term outcomes.

Franzone A, Pilgrim T, Haynes AG, Lanz J, Asami M, Praz F, Räber L, Roost E, Langhammer B, Windecker S, Stortecky S.

Eur Heart J Cardiovasc Imaging. 2017 Jul 29. doi: 10.1093/ehjci/jex181. [Epub ahead of print]

PMID:
28950318
7.

Echocardiographic Screening of Rheumatic Heart Disease in American Samoa.

Huang JH, Favazza M, Legg A, Holmes KW, Armsby L, Eliapo-Unutoa I, Pilgrim T, Madriago EJ.

Pediatr Cardiol. 2017 Sep 20. doi: 10.1007/s00246-017-1724-4. [Epub ahead of print]

PMID:
28932963
8.

Evolving Indications for Transcatheter Aortic Valve Interventions.

Franzone A, Pilgrim T, Stortecky S, Windecker S.

Curr Cardiol Rep. 2017 Sep 14;19(11):107. doi: 10.1007/s11886-017-0921-3. Review.

PMID:
28913586
9.

Orsiro cobalt-chromium sirolimus-eluting stent: present and future perspectives.

Iglesias JF, Roffi M, Degrauwe S, Secco GG, Aminian A, Windecker S, Pilgrim T.

Expert Rev Med Devices. 2017 Oct;14(10):773-788. doi: 10.1080/17434440.2017.1378091. Epub 2017 Sep 19.

PMID:
28889769
10.

Transcatheter Mitral Valve Replacement for Degenerated Bioprosthetic Valves and Failed Annuloplasty Rings.

Yoon SH, Whisenant BK, Bleiziffer S, Delgado V, Schofer N, Eschenbach L, Fujita B, Sharma R, Ancona M, Yzeiraj E, Cannata S, Barker C, Davies JE, Frangieh AH, Deuschl F, Podlesnikar T, Asami M, Dhoble A, Chyou A, Masson JB, Wijeysundera HC, Blackman DJ, Rampat R, Taramasso M, Gutierrez-Ibanes E, Chakravarty T, Attizzani GF, Kaneko T, Wong SC, Sievert H, Nietlispach F, Hildick-Smith D, Nombela-Franco L, Conradi L, Hengstenberg C, Reardon MJ, Kasel AM, Redwood S, Colombo A, Kar S, Maisano F, Windecker S, Pilgrim T, Ensminger SM, Prendergast BD, Schofer J, Schaefer U, Bax JJ, Latib A, Makkar RR.

J Am Coll Cardiol. 2017 Aug 29;70(9):1121-1131. doi: 10.1016/j.jacc.2017.07.714.

PMID:
28838360
11.

Frequency, Timing, and Impact of Access-Site and Non-Access-Site Bleeding on Mortality Among Patients Undergoing Transcatheter Aortic Valve Replacement.

Piccolo R, Pilgrim T, Franzone A, Valgimigli M, Haynes A, Asami M, Lanz J, Räber L, Praz F, Langhammer B, Roost E, Windecker S, Stortecky S.

JACC Cardiovasc Interv. 2017 Jul 24;10(14):1436-1446. doi: 10.1016/j.jcin.2017.04.034.

PMID:
28728657
12.

Effects of coronary artery disease in patients undergoing transcatheter aortic valve implantation: A study of age- and gender-matched cohorts.

Franzone A, Stortecky S, Räber L, Heg D, Yamaji K, Piccolo R, Asami M, Lanz J, Praz F, Koskinas K, Zanchin T, Wenaweser P, Valgimigli M, Jüni P, Pilgrim T, Windecker S.

Int J Cardiol. 2017 Sep 15;243:150-155. doi: 10.1016/j.ijcard.2017.05.071. Epub 2017 May 17.

PMID:
28536005
13.

Rates and predictors of hospital readmission after transcatheter aortic valve implantation.

Franzone A, Pilgrim T, Arnold N, Heg D, Langhammer B, Piccolo R, Roost E, Praz F, Räber L, Valgimigli M, Wenaweser P, Jüni P, Carrel T, Windecker S, Stortecky S.

Eur Heart J. 2017 Jul 21;38(28):2211-2217. doi: 10.1093/eurheartj/ehx182.

PMID:
28430920
14.

Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials.

Costa F, van Klaveren D, James S, Heg D, Räber L, Feres F, Pilgrim T, Hong MK, Kim HS, Colombo A, Steg PG, Zanchin T, Palmerini T, Wallentin L, Bhatt DL, Stone GW, Windecker S, Steyerberg EW, Valgimigli M; PRECISE-DAPT Study Investigators.

Lancet. 2017 Mar 11;389(10073):1025-1034. doi: 10.1016/S0140-6736(17)30397-5.

PMID:
28290994
15.

Prognostic impact of invasive haemodynamic measurements in combination with clinical and echocardiographic characteristics on two-year clinical outcomes of patients undergoing transcatheter aortic valve implantation.

Franzone A, O'Sullivan CJ, Stortecky S, Heg D, Lanz J, Vollenbroich R, Praz F, Piccolo R, Asami M, Roost E, Räber L, Valgimigli M, Windecker S, Pilgrim T.

EuroIntervention. 2017 Apr 7;12(18):e2186-e2193. doi: 10.4244/EIJ-D-16-00790.

16.

Type 2 myocardial infarction: incidence, presentation, treatment and outcome in routine clinical practice.

Radovanovic D, Pilgrim T, Seifert B, Urban P, Pedrazzini G, Erne P.

J Cardiovasc Med (Hagerstown). 2017 May;18(5):341-347. doi: 10.2459/JCM.0000000000000504.

PMID:
28107211
17.

Transcatheter Aortic Valve Replacement for the Treatment of Pure Native Aortic Valve Regurgitation: A Systematic Review.

Franzone A, Piccolo R, Siontis GC, Lanz J, Stortecky S, Praz F, Roost E, Vollenbroich R, Windecker S, Pilgrim T.

JACC Cardiovasc Interv. 2016 Nov 28;9(22):2308-2317. doi: 10.1016/j.jcin.2016.08.049. Epub 2016 Oct 26. Review.

PMID:
28026742
18.

Impact of Patient and Lesion Complexity on Long-Term Outcomes Following Coronary Revascularization With New-Generation Drug-Eluting Stents.

Koskinas KC, Taniwaki M, Rigamonti F, Heg D, Roffi M, Tüller D, Muller O, Vuillomenet A, Cook S, Weilenmann D, Kaiser C, Jamshidi P, Jüni P, Windecker S, Pilgrim T.

Am J Cardiol. 2017 Feb 15;119(4):501-507. doi: 10.1016/j.amjcard.2016.10.038. Epub 2016 Nov 16.

PMID:
27923461
19.

The impact of functional vs degenerative mitral regurgitation on clinical outcomes among patients undergoing transcatheter aortic valve implantation.

Vollenbroich R, Stortecky S, Praz F, Lanz J, Franzone A, Zuk K, Heg D, Valgimigli M, O'Sullivan CJ, Heinisch C, Roost E, Wenaweser P, Windecker S, Pilgrim T.

Am Heart J. 2017 Feb;184:71-80. doi: 10.1016/j.ahj.2016.10.015. Epub 2016 Oct 28.

PMID:
27892889
20.

Repositionable Versus Balloon-Expandable Devices for Transcatheter Aortic Valve Implantation in Patients With Aortic Stenosis.

Pilgrim T, Stortecky S, Nietlispach F, Heg D, Tueller D, Toggweiler S, Ferrari E, Noble S, Maisano F, Jeger R, Roffi M, Grünenfelder J, Huber C, Wenaweser P, Windecker S.

J Am Heart Assoc. 2016 Nov 17;5(11). pii: e004088.

Supplemental Content

Loading ...
Support Center